Baicalein Protects against Repeated Unpredictable Stress-Induced Depression-like Behavior in Mice

Abstract Baicalein, an active flavonoid derived from the root of Scutellaria baicalensis, has been extensively utilized in the treatment of stress-related neuropsychiatric disorders, encompassing behaviors indicative of depression and anxiety. The precise neurochemical and molecular biological mechanisms underlying the effect of baicalein on depression-like behavior have yet to be elucidated. In the current study, mice were administered baicalein at dosages of 10, 20, or 40 mg/kg (intraperitoneally) 30 minutes before being subjected to daily exposure to unpredictable stress over a period of 14 days. The tail suspension test and the forced swimming test, along with the novelty suppressed feeding test and the sucrose preference test, were employed to assess the protective effects of baicalein against depression- and anxiety-like behaviors induced by chronic stress. The outcomes indicated that baicalein notably reduced the duration of immobility in both the forced swimming test and tail suspension test, elevated sucrose consumption, and diminished the latency to feed, thereby reflecting its antidepressant and anxiolytic properties. Additionally, baicalein elevated the concentrations of serotonin and dopamine and suppressed monoamine oxidase activity within the hippocampus and cortex of stressed mice. Following baicalein treatment, the levels of cyclic adenosine monophosphate and the messenger RNA expression of the brain-derived neurotrophic factor were also observed to increase in these brain regions. These results suggest that baicalein may safeguard mice from depression- and anxiety-like behaviors precipitated by chronic stress, potentially through the augmentation of monoamine levels by inhibiting monoamine oxidase activity, and by stimulating the production of cyclic adenosine monophosphate and brain-derived neurotrophic factor in brain areas implicated in emotional disorders. Baicalein could prove to be a significant agent for the prevention or mitigation of the multifaceted symptoms associated with depression and anxiety.

Authors

Institutions

Publication Details

Journal
Pharmacopsychiatry
Published
2026-11-03
DOI
https://doi.org/10.1055/a-2975-3128
Primary Topic
Flavonoids in Medical Research
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Baicalein Protects against Repeated Unpredictable Stress-Induced Depression-like Behavior in Mice

Jian Wan, Min Zhou, Lina Ruan, Chuancui Wang et al.
1 links
Pharmacopsychiatry
Flavonoids in Medical Research
article

Baicalein Protects against Repeated Unpredictable Stress-Induced Depression-like Behavior in Mice

Jian Wan, Min Zhou, Lina Ruan, Chuancui Wang, Na Liu, Yan Jiang, Yuping Liang
article en

Abstract

Abstract Baicalein, an active flavonoid derived from the root of Scutellaria baicalensis, has been extensively utilized in the treatment of stress-related neuropsychiatric disorders, encompassing behaviors indicative of depression and anxiety. The precise neurochemical and molecular biological mechanisms underlying the effect of baicalein on depression-like behavior have yet to be elucidated. In the current study, mice were administered baicalein at dosages of 10, 20, or 40 mg/kg (intraperitoneally) 30 minutes before being subjected to daily exposure to unpredictable stress over a period of 14 days. The tail suspension test and the forced swimming test, along with the novelty suppressed feeding test and the sucrose preference test, were employed to assess the protective effects of baicalein against depression- and anxiety-like behaviors induced by chronic stress. The outcomes indicated that baicalein notably reduced the duration of immobility in both the forced swimming test and tail suspension test, elevated sucrose consumption, and diminished the latency to feed, thereby reflecting its antidepressant and anxiolytic properties. Additionally, baicalein elevated the concentrations of serotonin and dopamine and suppressed monoamine oxidase activity within the hippocampus and cortex of stressed mice. Following baicalein treatment, the levels of cyclic adenosine monophosphate and the messenger RNA expression of the brain-derived neurotrophic factor were also observed to increase in these brain regions. These results suggest that baicalein may safeguard mice from depression- and anxiety-like behaviors precipitated by chronic stress, potentially through the augmentation of monoamine levels by inhibiting monoamine oxidase activity, and by stimulating the production of cyclic adenosine monophosphate and brain-derived neurotrophic factor in brain areas implicated in emotional disorders. Baicalein could prove to be a significant agent for the prevention or mitigation of the multifaceted symptoms associated with depression and anxiety.

Pharmacopsychiatry
Shanghai University (CN), Shandong University (CN), Wenzhou Medical University (CN), Westlake University (CN), Xi'an Honghui Hospital (CN), Shanghai University of Medicine and Health Sciences (CN), Affiliated Hangzhou First People's Hospital, Westlake University, School of Medicine (CN), Changzhou No.2 People's Hospital (CN), Pudong New Area People's Hospital (CN), Nanjing Medical University (CN), Xi'an Jiaotong University (CN)
Good health and well-being
Openalex Percentile: Top 100%
Flavonoids in Medical Research
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon